×
戻る Agenda
S3-1 - What’s new in ICH guidelines? (1)
Session Chair(s)
Tamei Elliott, MS
Director, Global Scientific Content
DIA, United States
Janis Bernat, MSC
Director, Scientific and Regulatory Affairs
IFPMA, Switzerland
Speaker(s)
Young Su Noh, MPHARM
Hanmi Pharmaceuticals , Korea, Republic of